In the unadjusted analyses of categorical outcomes, women without obesity taking prescription opioids had higher odds of metabolic syndrome, high waist circumference, low HDL, high triglycerides, high mean corpuscular volume, high serum ferritin, and low serum transferrin saturation (Supplemental Table S6). This evidence concerns the gene TF and metabolic syndrome.